Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.1K
3.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

8.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.3K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.4K
T Cell Types and Functions01:24

T Cell Types and Functions

3.3K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting STAT5A via CRISPR/Cas9 restores TKI sensitivity in resistant chronic myeloid leukemia cells.

Medical oncology (Northwood, London, England)·2026
Same author

Spatial Mapping of Genetic Liability to Psychiatric Disorders in the Adult Human Hippocampus.

Biological psychiatry global open science·2026
Same author

Lineage-specific transcriptomic signatures and therapeutic target discovery in myeloid and lymphoid leukemias.

Personalized medicine·2026
Same author

Chemosensitizing effect of apigenin on T-ALL cell therapy.

Frontiers in pharmacology·2025
Same author

LEP and FOXO1 genes, as a proposed tumor suppressor autophagic cell death related genes, can be targeted by antidiabetic therapy in nondiabetic breast cancer patients.

Discover oncology·2025
Same author

Determination of survival associated genetic biomarkers to discover novel therapeutic targets for acute myeloid leukaemia.

Journal of chemotherapy (Florence, Italy)·2025

Related Experiment Video

Updated: Mar 31, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.9K

T cells in tumor microenvironment.

Yağmur Kiraz1,2, Yusuf Baran1,2, Ayten Nalbant3

  • 1Department of Molecular Biology and Genetics, Molecular Immunology and Gene Regulation Laboratory, Izmir Institute of Technology, Urla, 35430, İzmir, Turkey.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|October 19, 2015
PubMed
Summary

Tumor microenvironment immune cells, particularly T cells, significantly influence cancer progression. Understanding T helper cell subsets within this environment is crucial for predicting patient outcomes.

Keywords:
Cancer immunologyT cellsT helper cellsTh17 cellsTumor microenvironment

More Related Videos

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

21.1K
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

8.3K

Related Experiment Videos

Last Updated: Mar 31, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.9K
Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

21.1K
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

8.3K

Area of Science:

  • Oncology
  • Immunology
  • Cancer Biology

Background:

  • Tumors develop within a specialized niche known as the tumor microenvironment (TME).
  • The TME comprises diverse cellular and non-cellular components, including immune cells, which critically regulate tumor fate.
  • Immune cell populations, their densities, and functional states within the TME are key determinants of tumor progression and patient outcomes.

Purpose of the Study:

  • To review the role of immune system components within the tumor microenvironment.
  • To specifically detail the subsets of T helper cells and their functions in the TME.
  • To elucidate how T cell behaviors in the TME impact tumor progression and patient prognosis.

Main Methods:

  • Literature review focusing on T cell subsets within the tumor microenvironment.
  • Analysis of existing studies detailing immune cell interactions and functions in cancer.
  • Synthesis of data on T helper cell diversity and their impact on tumor biology.

Main Results:

  • T cells are integral components of the tumor microenvironment, exhibiting diverse roles.
  • Specific T helper cell subsets demonstrate distinct functional activities within the TME.
  • The balance and activity of these T cell subsets correlate with tumor progression and patient outcomes.

Conclusions:

  • T cells, especially T helper cell subsets, are critical modulators of the tumor microenvironment.
  • Understanding the nuanced roles of these immune cells offers potential therapeutic targets.
  • Further research into T cell dynamics within the TME is essential for improving cancer treatment strategies.